The New Zealand medical journal
-
In New Zealand laboratories the measurement of glycated haemoglobin (HbA1c) for diagnosis of diabetes is now only reported in SI units of mmol/mol. HbA1c is now recommended as the preferred test to diagnose diabetes in most circumstances. ⋯ For patients with an initial HbA1c result of 41-49 mmol/mol, cardiovascular risk assessment and lifestyle interventions are recommended with repeat HbA1c screening in 6-12 months. For patients whose HbA1c is less than and equal to 40 mmol/mol, repeat screening (including for CVD risk) at intermittent intervals is recommended as per published guidelines.
-
Medical schools need to justify their range of selection tools and processes. This paper describes the selection tools used at one university in New Zealand (Auckland), which combine a measure of academic achievement, score on a test of general cognitive ability, and score in a structured interview. Further, it describes considerations in justifying the decision to continue with an interview as part of the selection process. This information may be of use to stakeholders in the Auckland medical programme, and to other schools evaluating their admission tools.